Skip to main content
Clinical Trials/NCT06387485
NCT06387485
Recruiting
N/A

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning

Ricoh USA, Inc.3 sites in 1 country150 target enrollmentMarch 1, 2024

Overview

Phase
N/A
Intervention
CT/MRI
Conditions
Sarcoma, Ewing
Sponsor
Ricoh USA, Inc.
Enrollment
150
Locations
3
Primary Endpoint
Operative time
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

This prospective, multi-center, randomized controlled study aims to assess the efficacy of utilizing 3D printed models in preoperative planning for the excision of tumors involving bony structures within the body. The study is expected to last approximately 12 months and involve up to 150 subjects across up to 5 sites. Subjects will be randomized in a 1:1 ratio into either the experimental arm, utilizing 3D printed models and imaging, or the active comparator arm, using only imaging.

Primary endpoint: Operative time of surgical procedure.

Secondary endpoints: Reduction of blood loss, proportion of postoperative adverse events, and negative tumor margins.

Exploratory endpoints: Surgical planning ease, changes in surgical plan, and surgeon satisfaction.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
July 31, 2027
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ricoh USA, Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects must be at least 13 years of age.
  • Subjects must have the ability to provide written informed consent.
  • Subjects must have tumor(s) invading bone and requiring surgical excision including but not limited to craniomaxillofacial, spine, long bone, and pelvis.
  • Subjects must be willing to have quality cross-sectional imaging that will allow for use to develop a 3D printed model.

Exclusion Criteria

  • Pregnant or nursing women.
  • Subjects that have a serious systemic pathology.
  • Subjects that have clotting disorders.
  • Subjects that have uncontrolled hypertension.
  • Subjects that are HIV-positive.
  • Subjects that are unable to be randomized; i.e surgical team prefers to use either 3D model or standard cross-sectional imaging for surgical pre-planning.
  • Subject anatomy has changed substantially since the date medical imaging from which the model is derived was obtained (as applicable).
  • Subject is a poor surgical or poor study candidate which may include, any medical, social or psychological problem that could complicate the procedure.

Arms & Interventions

Standard Imaging

Participants in this arm will undergo tumor excision with prior planning utilizing only Imaging (CT or MRI) without development of a 3D printed model

Intervention: CT/MRI

3D Printed Anatomic Model

Participants in this arm will have tumors excised with prior planning utilizing 3D printed models and Imaging (CT or MRI).

Intervention: 3D Printed Anatomic Model

3D Printed Anatomic Model

Participants in this arm will have tumors excised with prior planning utilizing 3D printed models and Imaging (CT or MRI).

Intervention: CT/MRI

Outcomes

Primary Outcomes

Operative time

Time Frame: Incision to closure

Operative time of surgical procedure based on incision and closure time

Secondary Outcomes

  • Tumor margin status(Post-surgery (+3 days))
  • Blood loss(Incision to closure)
  • Adverse Events(Surgery to 90 days post-surgery)

Study Sites (3)

Loading locations...

Similar Trials